Literature DB >> 15108353

P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex.

Yubo Sun1, Xiao-Rong Zeng, Leonor Wenger, Gary S Firestein, Herman S Cheung.   

Abstract

We have previously reported that human matrix metalloproteinase-1 (MMP1) is a p53 target gene subject to down-regulation (Sun et al. [1999]: J Biol Chem 274:11535-11540]. In the present study, we demonstrate that the down-regulation of the human -83MMP1 promoter fragment by p53 was abolished when the -72AP-1 site was eliminated and that a GAL4-cJun-mediated but not a GAL4-Elk1-mediated induction of pFR-luci was effectively inhibited by p53 suggesting an AP-1 dependent but AP-1 binding independent mechanism. Results from gel mobility shift assays were consistent with an AP-1 binding independent mechanism. We also demonstrate that both p300 and TATA box binding proteins cooperated with the transcription factor AP-1 to induce the promoter of MMP1; however, p53 only inhibited the p300-mediated induction of the MMP1 promoter and the inhibition was -72AP-1 dependent. Furthermore, the down-regulation of the MMP1 promoter and mRNA by p53 could be reversed by p300 and by a p53 binding p300 fragment that had no coactivator activity. Taken together, these results indicate that p53 down-regulates MMP1 mainly by disrupting the communications between the transactivator AP-1 and the basal transcriptional complex, which are partially mediated by p300. Finally, by using p53 truncated mutant constructs, we demonstrate that both the N-terminal activation domain and the C-terminal oligomerization domains of p53 were required for the down-regulation of MMP1 transcription. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108353     DOI: 10.1002/jcb.20044

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

1.  Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors.

Authors:  Jing Zhou; Constance Brinckerhoff; Susan Lubert; Kui Yang; Jasmine Saini; Jeffrey Hooke; Richard Mural; Craig Shriver; Stella Somiari
Journal:  Cancer Invest       Date:  2011-11       Impact factor: 2.176

2.  Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.

Authors:  Jian Huang; Keqiang Chen; Jiaqiang Huang; Wanghua Gong; Nancy M Dunlop; O M Zack Howard; Xiuwu Bian; Yuqi Gao; Ji Ming Wang
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

3.  Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.

Authors:  Pankaj K Singh; Michelle E Behrens; John P Eggers; Ronald L Cerny; Jennifer M Bailey; Kandavel Shanmugam; Sandra J Gendler; Eric P Bennett; Michael A Hollingsworth
Journal:  J Biol Chem       Date:  2008-07-14       Impact factor: 5.157

4.  TP53 mutations coincide with the ectopic expression of activation-induced cytidine deaminase in the fibroblast-like synoviocytes derived from a fraction of patients with rheumatoid arthritis.

Authors:  H Igarashi; J Hashimoto; T Tomita; H Yoshikawa; K Ishihara
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

5.  CMV promoter is repressed by p53 and activated by JNK pathway.

Authors:  Marianna Rodova; Renuka Jayini; Reddy Singasani; Elizabeth Chipps; M Rafiq Islam
Journal:  Plasmid       Date:  2013-02-01       Impact factor: 3.466

6.  Trp53 deficiency protects against acute intestinal inflammation.

Authors:  Martina E Spehlmann; Carolin F Manthey; Sara M Dann; Elaine Hanson; Sukhman S Sandhu; Linus Y Liu; Farid K Abdelmalak; Michaela A Diamanti; Kristin Retzlaff; Jürgen Scheller; Stefan Rose-John; Florian R Greten; Jean Y J Wang; Lars Eckmann
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

7.  Enhanced endothelial cell senescence by lithium-induced matrix metalloproteinase-1 expression.

Authors:  Ian T Struewing; Samuel N Durham; Corey D Barnett; Catherine D Mao
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

Review 8.  Involvement of stromal p53 in tumor-stroma interactions.

Authors:  Jair Bar; Neta Moskovits; Moshe Oren
Journal:  Semin Cell Dev Biol       Date:  2009-11-13       Impact factor: 7.727

9.  p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells.

Authors:  Shui Ping Tu; Alfred L Chi; Walden Ai; Shigeo Takaishi; Zina Dubeykovskaya; Michael Quante; James G Fox; Timothy C Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-18       Impact factor: 4.052

10.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.